Clin2
NCT07284290Possibly a fitRecruiting

Brain imaging, thinking, and medication study for Lewy body dementia

Dementia With Lewy BodiesParkinson Disease DementiaHealthy Controls

Part of Brain & nervous system, Mental health clinical trials.

This study looks at how brain changes affect attention and thinking in people with Lewy body dementia. It includes brain scans, an EEG, and a medication option to see if it helps with symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
120 people
Ages
50 years to 89 years
Study type
Interventional

Who can take part

  • You are 50 to 89 years old.
  • You have a diagnosis of Lewy body dementia, Parkinson's with dementia or mild thinking problems, or mild cognitive impairment with Lewy bodies.
  • You are willing to have brain scans and an EEG (brain wave test).
  • You can speak and read English well enough to do thinking tests.
  • You do not have a history of seizures, epilepsy, or certain heart or brain conditions.
  • You are not pregnant or planning to become pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04760860Not yet recruiting· Phase 1/Phase 2
Studying a blood pressure medicine for dementia with Lewy bodies

This trial tests a medicine normally used for high blood pressure (terazosin) to see if it can improve thinking or slow down decline in people with dementia with Lewy bodies. It's an early-stage study, so the goal is also to check safety.

Iowa City, Iowa
NCT07122908Recruiting· Phase 1/Phase 2
Magnetic brain stimulation for thinking in Lewy body dementia

This trial tests a noninvasive magnetic brain stimulation (rTMS) treatment for people with dementia with Lewy bodies. The treatment aims to help improve thinking and memory. It involves 1–2 weeks of daily sessions, and you'll have memory tests and brain scans during the study.

Seoul, Seoul
NCT04588285Recruiting· Phase 2
Ambroxol for new and early dementia with Lewy bodies

This trial tests whether ambroxol (a mouth medicine) can help people with new or early dementia with Lewy bodies (DLB) or mild cognitive impairment linked to DLB. Participants take the medicine for about 18 months while the study tracks safety and changes over time.

Haugesund, Haugesund
NCT07602296Not yet recruiting
Red-light therapy for dementia with Lewy bodies

This trial tests whether shining a special red light on the head can improve symptoms, daily life, and brain activity in people with dementia with Lewy bodies. The treatment is non-invasive and may help with thinking and movement problems.

Strasbourg
NCT05460143Recruiting
Optical brain scanning to study memory and thinking

This study uses brain “optical” and possibly MRI scans to understand how thinking and memory work in people with Lewy body dementia, Alzheimer’s disease, or mild memory problems. It may help researchers find better ways to measure brain changes and cognition over time.

Cambridge
NCT07240805Not yet recruiting
Digital health tools for monitoring PSP and Lewy body dementia

This study is testing whether digital health tools (like wearable sensors) can better track symptoms of certain brain conditions (PSP, DLB, and MCI with Lewy bodies). It aims to improve monitoring and care for people with these conditions.

Lutherville, Maryland

Hear when a new Dementia With Lewy Bodies trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.